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ABSTRACT Salmonella enterica serovar Typhimurium is one of approximately 2,500
distinct serovars of the genus Salmonella but is exceptional in its wide distribution
in the environment, livestock, and wild animals. S. Typhimurium causes a large pro-
portion of nontyphoidal Salmonella (NTS) infections, accounting for a quarter of in-
fections, second only to S. enterica serovar Enteritidis in incidence. S. Typhimurium
was once considered the archetypal broad-host-range Salmonella serovar due to its
wide distribution in livestock and wild animals, and much of what we know of the
interaction of Salmonella with the host comes from research using a small number
of laboratory strains of the serovar (LT2, SL1344, and ATCC 14028). But it has be-
come clear that these strains do not reﬂect the genotypic or phenotypic diversity of
S. Typhimurium. Here, we review the epidemiological record of S. Typhimurium and
studies of the host-pathogen interactions of diverse strains of S. Typhimurium. We
present the concept of distinct pathovariants of S. Typhimurium that exhibit diver-
sity of host range, distribution in the environment, pathogenicity, and risk to food
safety. We review recent evidence from whole-genome sequencing that has revealed
the extent of genomic diversity of S. Typhimurium pathovariants, the genomic basis
of differences in the level of risk to human and animal health, and the molecular ep-
idemiology of prominent strains. An improved understanding of the impact of ge-
nome variation of bacterial pathogens on pathogen-host and pathogen-environment
interactions has the potential to improve quantitative risk assessment and reveal
how new pathogens evolve.
KEYWORDS Salmonella, Typhimurium, epidemiology, genomics, host adaptation,
phylogenetics, virulence
Salmonella remains a leading enteric bacterial pathogen in humans, domesticatedanimals, and wild animals worldwide. Infections in humans manifest as gastroen-
teritis, disseminated diseases (also called invasive nontyphoidal Salmonella disease)
including bacteremia and enteric fever, or focal infections. The outcome of infection
depends on the combination of the pathogen genotype, host species, and host
immune status. The burden of disease caused by NTS in the human population is
estimated to be up to 129.5 million cases each year, resulting in between 100,000 and
1 million deaths per year worldwide (1–4). Most infections result in a self-limiting
gastroenteritis with a low mortality rate. The majority of mortality in recent years, up to
700,000 deaths per year, is from around 2 to 3 million cases of disseminated NTS, which
primarily affects immunocompromised people in sub-Saharan Africa (5).
Salmonella serovars are distinguished by antigenic variation in long-chain lipopoly-
saccharides (LPS) and ﬂagella and exhibit considerable variation in host range and
outcome of infection (6). Two species comprise the genus, S. bongori and S. enterica.
The latter is further subdivided into 2,500 serovars belonging to seven subspecies (I, II,
IIIa, IIIb, IV, VI, and VII). All Salmonella strains are pathogens, due to the acquisition of
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major virulence factors early in the evolution of the genus, including a type III secretion
system (T3SS) encoded on Salmonella pathogenicity island 1 (SPI-1) and, in the case of
S. enterica, a second T3SS encoded on SPI-2 (7, 8). Salmonella is considered to be
primarily a gastrointestinal pathogen, since this is a common feature of most serovars.
However, host adaptation is often accompanied by a more severe disseminated
disease; examples of such host adaptation are thought to arise by evolution from
ancestors associated with gastroenteritis (6). Distinct host ranges and pathogenicities of
Salmonella species, subspecies, and serovars are evident from epidemiological surveil-
lance, clinical descriptions of disease in various hosts, and experimental infections. S.
enterica and S. bongori are likely to differ in disease potential and severity, with the
latter generally considered less virulent because it lacks the SPI-2-encoded type III
secretion system, which is involved in enhanced intracellular replication (9, 10). Of eight
subspecies comprising S. enterica, subspecies I (enterica) accounts for the vast majority
of human infections, probably because of its widespread distribution in domesticated
animals, while S. bongori and non-subspecies I serovars of S. enterica are generally
associated with cold-blooded animals (11). Subspecies I serovars exhibit a general host
adaptation to warm-blooded animals and speciﬁc host adaptation on a spectrum from
broad to exquisitely host restricted (6, 12). Host adaptation refers to the ability to
circulate in particular host species, and host-adapted strains may also be pathovariants
due to altered pathogenicity (6). Evolution of subspecies I resulted in over 1,500
serovars, with a few evolving to become host adapted and, therefore, restricted to
circulation in a single host species or closely related species. For example, S. enterica
serovar Typhi and S. enterica serovar Gallinarum circulate in human and Galliformes
(e.g., chicken) populations, respectively. Others exhibit a marked host preference and
are associated with disseminated disease, such as S. enterica serovar Choleraesuis and
S. enterica serovar Dublin, whose preferences are for pigs and cattle, respectively. The
host ranges of most of the approximately 1,500 serovars of S. enterica subspecies I are
poorly deﬁned but are generally considered to be relatively broad. However, the
distribution of Salmonella serovars in host species is far from homogenous in domes-
ticated animals, suggesting a degree of host preference. Surveillance in the United
Kingdom reveals distinct proportions of each serovar isolated from a different host
species (13). Around 95% of isolates from each host species are accounted for by 6 to
11 serovars, with the remainder made up of many minority serovars (13). However, it
is striking that in reports of the prevalence of Salmonella serovars in animal species, S.
Typhimurium is the only serovar that appears as one of the top two serovars for
virtually all host species (13, 14). For this reason, S. Typhimurium has been considered
the prototypical broad-host-range serovar. However, the epidemiology of S. Typhimu-
rium suggests a more complex mixture of pathovariants, some of which are highly host
adapted. While some strains of S. Typhimurium do indeed have a broad host range,
others exhibit a limited distribution within a single or related group of host species and
may also exhibit distinct pathogenicities and risks to food safety (15–20).
EPIDEMIOLOGY AND HOST RANGE OF SALMONELLA TYPHIMURIUM
PATHOVARIANTS
Subtyping of S. Typhimurium (antigenic formula 4,[5],12:i:1,2) for the purpose of
outbreak detection has historically been achieved using phage typing in many coun-
tries worldwide, phage typing being a scheme based on differential levels of suscep-
tibility to lysis by a panel of bacteriophages (21). The molecular basis of susceptibility
is not known but is likely to be inﬂuenced by variations in LPS and surface proteins that
are receptors for phages, modiﬁcation and restriction systems, and superinfection
exclusion systems encoded by prophages (22). National surveillance program data
provide over half a century of epidemiological data about the host ranges and
dynamics of S. Typhimurium epidemics caused by individual phage types (Table 1 and
Fig. 1) (14, 15). Inferences of epidemiology and host range from phage type data must,
however, be treated with caution because phage sensitivity does not provide direct
information about the phylogenetic relationship of a strain. A particular phage type
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may in some cases be polyphyletic, and therefore, two isolates with the same phage
type may potentially be nonclonal and exhibit distinct host ranges and pathogenicities.
However, a temporally deﬁned increase in the incidence of a particular phage type is
used to detect outbreaks and, over longer time intervals, to deﬁne epidemics (21). It is
important to note that there is no evidence that phage sensitivity itself has any direct
TABLE 1 Epidemiology and host ranges of Salmonella Typhimurium pathovariants
Phage type Sequence type Host range and epidemiology Reference(s)
DT9 ST19 Broad host range (primarily cattle), MDR
epidemic strain 1960 to 1975
21
DT204 ST19 Broad host range (primarily cattle), MDR
epidemic strain 1970 to 1985
21, 106
DT104 ST19 Broad host range (primarily cattle), MDR
pandemic strain 1990 to 2010
21, 64, 98
DT193/DT120a ST34 Broad host range (primarily porcine),
MDR pandemic 2005 to present
21, 59
U288 ST19 Porcine, MDR epidemic clone in pigs,
2000 to present, rare in humans
13, 107, 108
DT8 ST19 Ducks/geese 27–29
DT56var ST568 Wild birds (passerines) 30, 67
DT2 ST98 Wild birds (pigeon), endemic in pigeon
populations
30, 109
DT160 ST19 Wild birds, extended outbreak in New
Zealand, multiple hosts
31–33, 35
ND ST313 Disseminated disease in sub-Saharan
Africa, 1960 to present
43, 62
ND ST213 Emergent clone in Mexico in 2002 39
aS. 4,[5],12:i:.
FIG 1 Host range and plausible transmission routes of major S. Typhimurium phage types in humans,
pigs, cattle, wild avian species, ducks, and poultry. Dominant phage types are indicated in boldface, and
minority phage types in italics. Arrow colors matched to each phage type indicate probable transmission
routes based on the epidemiological record but may not include all possible routes. Line thickness
indicates relative level of transmission, and the question mark a hypothetical route of transmission of
ST313.
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impact on host range and/or pathogenesis, although this cannot be discounted
entirely. Phage typing is, however, an inexpensive and convenient surrogate for the
determination of phylogenetic groups. In comparison, multilocus sequence typing
(MLST), a subgenomic scheme using sequences from seven alleles, does provide
phylogenetic information, but this information is of relatively low resolution and
therefore not commonly used for surveillance (23).
The epidemiological record of S. Typhimurium phage types in domestic animals and
humans in England, Wales, and Germany is characterized by successive waves of a
dominant phage type, with each wave spanning approximately 10 to 15 years and
accounting for over 50% of all isolates at the peak of the epidemic (14). Strains of DT9,
DT204, DT104, and the current S. 4,[5],12:i: (monophasic Typhimurium variant) DT193/
DT120 have in turn been the dominant strains since the early 1960s in Germany (21).
However, the reason for the decline and replacement by successive strains is not well
understood. Two characteristics of strains that become most prevalent are multidrug
resistance (MDR) and a relatively broad host range (14). For example, the DT104 strain
was initially associated with cattle but became widespread in pigs, poultry, and some
wild animal species and had a typical pentaresistance pattern of ACSSuT (ampicillin,
chloramphenicol, streptomycin, sulfonamides, and tetracycline) (24), and while S.
4,[5],12:i: DT193/DT120 is primarily associated with pigs, the strain has since spread
to other species and has the resistance pattern ASSuT (25, 26).
Dominant MDR pandemic clones like DT9, DT204, DT104, and the current S.
4,[5],12:i: (monophasic) DT193/DT120 exemplify the broad-host-range pathogens
once considered typical of S. Typhimurium. However, many examples of host-
adapted S. Typhimurium pathovariants have also been described. The host adap-
tation of these variants is supported by the epidemiological record, and in some
cases, descriptions of clinical disease and experimental infections suggest that they
are also pathovariants. Some phage types exhibit a restricted distribution to
particular zoonotic reservoirs and are typically associated with gastroenteritis in
humans (DT8 and U288), while others are exclusively associated with severe dis-
seminated diseases in wild animal host populations but rarely associated with
disease in humans (DT2, DT99, and DT56). The host adaptation of S. Typhimurium
variants was recognized as long ago as 1937, when it was noted that Salmonella
from ducks has a distinct biotype (15). S. Typhimurium DT8 outbreaks of foodborne
disease reported in Germany (15), Ireland (27), and the United Kingdom (28, 29)
have been traced back to the consumption of raw or undercooked duck eggs, but
this phage type is rarely isolated from other zoonotic reservoirs (13, 15). Despite the
considerable degree of host adaptation exhibited by DT8 strains, they retain full
virulence in humans. The reported gastrointestinal symptoms of DT8 in humans, i.e.,
diarrhea and, in most cases, fever and nausea, are similar to those described for
other nontyphoidal serovars, and over half of infections are associated with bloody
diarrhea (27). S. Typhimurium variants of DT56 (DT56var) and DT40 have long been
associated with passerine salmonellosis, an often-fatal infection in birds in the order
Passeriformes that includes song birds, such as the ﬁnch and sparrow (30). These
phage types are dominant isolates from the carcasses of ﬁnches and sparrows in the
United Kingdom but are rarely isolated from livestock and poultry. Despite their
adaptation to circulation in avian populations, they are able to cause gastroenteritis
in people (31). S. Typhimurium DT160 is also a phage type typically associated with
the environment and moribund wild birds but not with nonavian species (31–34).
However, this phage type was also associated with an extended outbreak in New
Zealand between 1998 and 2012, with over 3,000 reported cases of salmonellosis in
people. During this time, DT160 was, atypically, widely distributed among poultry,
bovines, and felines, as well as in wild birds (35, 36), and may represent a distinct
variant.
Some phage types are particularly associated with speciﬁc wild bird populations and
rarely cause disease in people. Strains of the S. Typhimurium variant Copenhagen with
phage types DT2 and DT99 are examples, exhibiting exquisite adaption to the pigeon,
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where they cause severe disseminated disease (30). In Germany, there was considerable
concern over the potential risk to public health from S. Typhimurium variant Copen-
hagen (S. 4,12:i:1,2) that was common in pigeons, as this variant of Typhimurium was
also associated with disease in humans. However, ribotyping, biotyping and phage
typing of S. Typhimurium variant Copenhagen isolates from human clinical infections
and pigeons indicated a distinct variant in the pigeon population (37). Epidemiological
data from Germany spanning 25 years indicated that DT2 and DT99 accounted for
virtually all pigeon isolates but were rarely isolated from clinical infections in humans
(15). DT2 and DT99 strains exhibit differing and atypical pathogenicities in the mouse
and bovine ileal loop models of infection. DT2 and DT99 strains are attenuated in
experimental infections of mice and have differing abilities to induce ﬂuid accumula-
tion in the bovine ileal loop model of colitis (19, 38).
Other groups of strains with distinct epidemiology for human or animal infection
have been deﬁned using MLST. These include S. Typhimurium sequence type 213
(ST213), which was reported to account for a large proportion of clinical infections
in Mexico, and ST313, associated with disseminated disease in sub-Saharan Africa.
S. Typhimurium ST213 emerged around the year 2001 in several states in Mexico
and accounted for over 50% of isolates by 2005, displacing the previously dominant
ST19 strains (39, 40). The ST213 strains were characterized by plasmid-borne MDR,
including resistance to extended-spectrum cephalosporins and the lack of the
virulence plasmid pSLT. One ST213 strain isolated from a child with disseminated
disease was attenuated in experimental infections of genetically susceptible mice,
probably due to the lack of the virulence plasmid (41). ST213 strains have not been
reported outside Mexico, and the explanation for the rapid expansion in this clonal
group is not known.
S. Typhimurium ST313 strains accounted for over 90% of bloodstream isolates from
a number of countries across sub-Saharan Africa between 1995 and 2010 (42, 43).
Disseminated nontyphoidal Salmonella infection (invasive NTS) has been recognized as
a common cause of bloodstream infection in sub-Saharan Africa since the late 1980s (5,
44). Disseminated disease is generally uncommon in infections caused by nontyphoidal
Salmonella serovars, such as S. Typhimurium, and the high incidence of ST313 in
sub-Saharan Africa is at least in part associated with the relatively large population of
immunocompromised people (5). The major risk factors for disseminated NTS in
sub-Saharan Africa are HIV coinfection in adults and malaria or HIV coinfection or
malnutrition in children. Depletion of T helper type 17 (TH17) cells (45) and dysregu-
lation of the humoral response (46) have been identiﬁed as contributing factors in HIV
infection. Increased intestinal wall permeability (47) and impaired macrophage (48) and
neutrophil (49) function contribute to comorbidity with malaria. The lack of large-scale
surveillance of Salmonella in zoonotic reservoirs and people in sub-Saharan Africa limits
our understanding of the degree to which the ST313 genotype contributes to the
outcome of infection and whether it is truly a host-adapted pathovar. However, in one
study in Kenya, isolates to similar that of the index case could not be found in food, the
environment, or animals in close contact with the index case (50). Furthermore, despite
their prevalence in disseminated disease in sub-Saharan Africa, S. Typhimurium ST313
strains are not commonly isolated outside the continent (43). Few strains isolated
during routine surveillance in England and Wales were ST313, and most were geneti-
cally distinct from the two epidemic ST313 clades prevalent in sub-Saharan Africa (43,
51). However, ST313 strains from England and Wales that were present in the epidemic
ST313 clade prevalent in sub-Saharan Africa were signiﬁcantly more likely to be
bloodstream infections (52), suggesting that this particular clonal group of ST313 may
be innately predisposed to cause disseminated disease. Experimental infections of mice
and primates largely support the view that ST313 strains have altered pathogenicity
compared with those of commonly used laboratory strains, such as strains SL1344 and
ATCC 14028. An ST313 isolate hyperdisseminated from the intestine to systemic sites in
the murine model of infection and in poultry (16, 17, 53). Furthermore, ST313 strains
exhibit decreases in intestinal pathology in mice, ﬂuid accumulation and migration of
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inﬂammatory cells to the intestinal lumen in bovine ileal loops, and diarrhea in rhesus
macaques (53, 54).
POPULATION GENETICS OF S. TYPHIMURIUM PATHOVARIANTS
Whole-genome sequence analysis has brought new insights to Salmonella taxon-
omy. The phylogenetic tree of S. enterica subspecies I revealed that serovars are located
on deeply rooted branches in a star-shaped topology (Fig. 2A). The length of each
branch is proportional to the number of single nucleotide polymorphisms (SNPs) and
represents the level of divergence. Branches closer to the ancestor (root) are deﬁned by
SNPs that are shared by multiple strains, while terminal branches are deﬁned by
strain-speciﬁc SNPs. S. Enteritidis and S. Gallinarum are relatively closely related, yet
they exhibit profound differences in host range and pathogenicity, being broad host
range and highly host adapted to Galliformes birds, respectively, highlighting the
potential for evolution in relatively short periods of time (55, 56). S. Typhimurium is on
a deeply rooted branch, distinct from other serovars, with diversiﬁcation at the extreme
terminus of the lineage.
Historically, collections of strains intended to represent S. Typhimurium’s genetic
diversity in natural populations have been established based on phage type (57) and
multilocus enzyme electrophoresis (58). The whole-genome sequences of some of the
strains from these collections, along with additional contemporary strains representing
the common phage types isolated from animals and human clinical cases, have been
used to contextualize epidemics in sub-Saharan Africa (43) and the United Kingdom
(59). The phylogeny of S. Typhimurium reveals a star-shaped tree topology, similar to
that for serovars of S. enterica subspecies I but on a considerably smaller scale of
sequence divergence (Fig. 2B). Some lineages within the S. Typhimurium tree have
multiple short terminal branches, characteristic of clonal expansion of epidemic clones
(Fig. 2B). The diversity within S. Typhimurium based on the number of SNPs in the core
genome is approximately 2 orders of magnitude lower than that within S. enterica
subspecies I. S. Typhimurium has accumulated around 20,000 to 40,000 SNPs since
divergence from a common ancestor shared with other S. enterica serovars, correspond-
ing to an average nucleotide identity (ANI) of 98 to 99% (60, 61). In contrast, S.
Typhimurium strains accumulated approximately 400 to 600 SNPs, corresponding to
approximately 99.99% ANI (19, 59, 62). For comparison, Salmonella genomes exhibit
around 80% ANI with those of its nearest neighbor, Escherichia coli (63).
Two high-order subclades are evident in the S. Typhimurium tree; although only
weakly supported by sequence variation data, they nonetheless predominantly contain
S. Typhimurium strains with distinct epidemiology. The ﬁrst (Fig. 2B, pound sign [#])
contains strains almost entirely from cattle, pigs, and poultry with considerable diversity
at the terminal branches, formed by clonal expansion of the most recent pandemic
clones, the DT104 clade and the monophasic S. Typhimurium DT193/DT120 clade (59,
64). A clade in which all animal-derived isolates were from pigs included many strains
of phage type U288 that are epidemic in UK pig herds, suggesting that this could be
a pig-adapted clade (65). The second major subclade (Fig. 2B, asterisk [*]) is character-
ized by lineages that are deeply rooted, with less evidence of clonal expansion in the
sampled isolates, and contains strains isolated from a considerably greater diversity of
host species. Although strains from cattle and poultry are represented, no pig isolates
are present, but instead, strains from wild birds, including passerines and pigeons, are
present in multiple lineages. The prototypical laboratory strain SL1344 is present, along
with sopE-bearing strains of phage types DT204 and DT49 (66) that are likely related to
strains that were epidemic during the 1970s in Europe (14, 21). The second major
subclade also contains host-adapted pathovariants, including two lineages containing
DT2 and DT99 strains that are host adapted to pigeons (19), a lineage containing DT56
strains associated with passerine birds (67), the ST313 lineage containing two epidemic
expansions associated with disseminated nontyphoidal salmonellosis in sub-Saharan
Africa (43), and a lineage including DT8 strains adapted to circulation in duck popula-
tions (29).
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FIG 2 Phylogenetic relationships of Salmonella enterica subspecies I serovars and S. Typhimurium strains.
Maximum-likelihood trees of 15 S. enterica subspecies I serovars (A) and 194 S. Typhimurium strains (B)
based on sequence variation in the core genome. Trees are midpoint rooted (ﬁlled black circle). (B) The
inner circle indicates the source animal host species for each S. Typhimurium strain, with color code as
shown in the key. The outer circle indicates ST19 (black line), other STs (gray box), and strains with an
unassigned ST (line break). Strains with a published complete, closed genome sequence are indicated by
small black circles at leaf nodes, and the names of key strains are in italics. The locations of key clades
are indicated with boldface black font. The positions of two major clades containing strains with distinct
epidemiology are indicated near the root (# and *).
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The diversity of sequence type (ST) within the S. Typhimurium clade is low and,
in most cases, does not discriminate between subclades on major lineages. The vast
majority of isolates are ST19, reﬂecting the ancestral type; these account for most
of the strains that are associated with gastroenteritis and exhibit considerable
diversity (Fig. 2B). A few additional STs are present as discrete subclades, and in
some cases, these have undergone considerable divergence and establishment of
multiple lineages, as is the case for ST313 (43).
COMPARATIVE GENOMICS OF BROAD-HOST-RANGE SALMONELLA TYPHIMURIUM
The vast majority of what is known of the physiology, biochemistry, genetics, and
pathogenicity of Salmonella comes from over 70 years of experimental research using
just three strains of S. Typhimurium: LT2, SL1344, and ATCC 14028. Two additional
strains, SR11 and UK1, have been used by some laboratories, but these are closely
related to SL1344 and ATCC 14028, respectively (Fig. 2B) (68). S. Typhimurium LT2 strain
85 was originally isolated at the Stoke-Mandeville Hospital in the United Kingdom in
1946 (57), and following its use in the ﬁrst transduction experiments (69), it became the
strain of choice for many investigations (70). However, the utility of the LT2 strain for
studying host-pathogen interactions was limited by its attenuation in the murine
typhoid model, at least in part due to defective RpoS (71). Consequently, strains SL1344
and ATCC 14028, isolated from bovine and chicken hosts, respectively, are commonly
used in laboratories for pathogenesis studies (72, 73). Both SL1344 and ATCC 14028
exhibit virulence in a wide range of hosts, including mice, cattle, and poultry, with a
notable difference being that SL1344 bears the sopE gene, located on a lysogenic
phage, that results in increased enteropathogenesis (74). The evidence from epidemi-
ology and experimental infection of animals would suggest that SL1344 and ATCC
14028 represent the typical broad-host-range phenotype classically associated with S.
Typhimurium. However, it is noteworthy that SL1344 and ATCC 14028 are present in
the part of the S. Typhimurium phylogenetic tree that is distinct from recent MDR
pandemic clades (DT104 and S. 4,[5],12:i: DT193/DT120) and more closely related to
lineages containing pathovariants adapted to avian hosts (Fig. 2B). The divergence of
SL1344 and ATCC 14028 highlights the need to understand the impact of genotypic
differences on pathogen-host and pathogen-environment interactions in order to
interpret the large body of work with these strains with regard to disease caused by
currently circulating pandemic strains.
The sizes of the chromosomes of LT2, SL1344, and ATCC 14028 are similar, differing
by no more than about 20 kb (LT2, 4,857,432 bp; SL1344 4,878,012, bp; and ATCC
14028, 4,870,265 bp) (60, 72, 73). The genomes of the three strains are highly syntenic
and show conservation of Salmonella pathogenicity islands (SPIs) (75), and most of the
variation in coding capacity is restricted to prophage sequences and plasmids. This was
also true for a larger collection of 20 complete S. Typhimurium genomes (76). The gene
model for the chromosome of strain SL1344 has 148 genes not present in strain LT2,
and these are almost entirely accounted for by the presence of partial and complete
prophage elements SLP281, SLP203, and SLP289 that are absent from LT2 and regions
of variable sequence in the FELS-2 prophage (73). The LT2 genome likewise contains
genes absent from SL1344 due to additional prophages.
The variable presence of plasmids also contributes signiﬁcantly to differences in
coding capacity. All three laboratory strains contain the 90-kb virulence plasmid
pSLT (77), while strain SL1344 carries an additional 112 genes on two plasmids,
pRSF1010 and pCol1b9 (73). The initial annotation of strain LT2 resulted in a gene
model consisting of 4,489 genes on the chromosome (60). However, improved gene
prediction models and mapping of transcription start sites to the SL1344 whole-
genome sequence assembly using RNA sequence data resulted in 4,899 predicted
genes (73).
The coding capacity of bacterial genomes can be considerably decreased by the
formation of pseudogenes, due to sequence polymorphisms, insertions, or deletions
introducing a premature stop codon, which is termed “genome degradation” (78).
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Host-restricted serovars like S. Gallinarum and S. Typhi contain around 200 to 300
pseudogenes, up to 5% of the original coding capacity (55, 61). Overrepresented
degradation of genes associated with intestinal colonization and persistence, including
those involved in anaerobic metabolism, is consistent with the loss of functions no
longer required for the disseminated-disease lifestyle adopted by these serovars (79). S.
Typhimurium strain SL1344 contains 54 pseudogenes, 38 of which are also pseudo-
genes in LT2, and a further 6 are also pseudogenes in strain ATCC 14028 (60, 72, 73).
Just 10 pseudogenes are speciﬁc to strain SL1344, and a similar number are speciﬁc to
ATCC 14028, with reference to these three strains (72). Hence, most pseudogenes in
commonly used laboratory strains formed in a common ancestor of S. Typhimurium
and so could not contribute to strain-speciﬁc characteristics. Strain-speciﬁc pseudo-
genes are of potential interest, as they could contribute to strain-speciﬁc phenotypes.
In SL1344 and ATCC 14028, strain-speciﬁc pseudogenes generally encode proteins of
unknown function or of a nonspeciﬁc nature but, notably, they do not include virulence
genes or regulators.
Care must be taken in the interpretation of the potential impact of pseudogene
formation, as some proteins may remain functional due to a small truncation or if
proteins are composed of multiple domains. Even a relatively large truncation that
nonetheless results in retention of functional domains may not abrogate function
entirely. For example, the RatB protein is present in the full-length form of 2,435
residues in strain LT2 (RatBLT2), but the introduction of a frameshift in the coding
sequence in both ATCC 14028 and SL1344 results in a protein of 1,947 residues.
However, the truncated RatB of ATCC 14028 (RatBATCC 14028) appears to remain func-
tional, since deletion of the ratB gene resulted in decreased colonization of the cecum
in experimentally infected mice, a phenotype that was complemented by the 1,947-
residue-encoding ratB (80). A possible explanation for this observation is that RatB is
composed of repeating sequence modules, and loss of a subset of these does not result
in loss of function. The primary amino acid sequence of RatBLT2 contains eight imper-
fect repeats, and that of RatBATCC 14028 contains six complete repeats. The assumption
that pseudogene formation is equivalent to a null mutation in all cases may therefore
result in misleading conclusions. In practice, the exhaustive functional analysis of all
polymorphisms that lead to pseudogenes is impractical in comparative genomics
studies, and this remains an important caveat to be considered.
Complete, closed, whole-genome sequences have been determined for the MDR
pandemic strains S. Typhimurium DT104 (strain NCTC13348) and S. 4,[5],12:i: DT193/
DT120 (strain SO4698-09) and reveal extensive similarity to model laboratory strains,
with some key differences that are likely to have contributed to their success (59, 64,
81). A key feature of DT104 is the presence of Salmonella genomic island 1 (SGI-1), an
integrative conjugative element bearing a number of genes conferring resistance to
multiple drugs that can be mobilized with a helper conjugative plasmid (82). S.
4,[5],12:i: DT193/DT120 strain SO4698-09 contains a composite transposon inserted
adjacent to the ﬂjB and iro loci that encodes resistance to multiple antibiotics and
mercury. The strain additionally contains a putative integrative conjugative element
(ICE), termed SGI-4, that was acquired shortly before clonal expansion and is absent
from all other Salmonella genomes reported to date. It bears genes predicted to confer
resistance to arsenic, copper, and silver. The presence of SGI-4 correlated with en-
hanced resistance to copper, a phenotype that has been proposed have possibly
contributed to the success of the S. 4,[5],12:i: DT193/DT120 clone in pig herds, where
copper is used as a growth promoter due to its antimicrobial properties (59). Complete,
closed genome sequences are also available for a number of other S. Typhimurium
strains (Fig. 1B), but a detailed comparative genome analysis has not been reported.
These include whole-genome sequences of 10 S. Typhimurium strains from cattle, beef
products, and human clinical cases in the United States, including several S. 4,[5],12:i:
isolates similar to the epidemic clade in the United Kingdom (83).
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COMPARATIVE GENOMICS OF HOST-ADAPTED S. TYPHIMURIUM
PATHOVARIANTS
Strains of S. Typhimurium ST313 form a clade mainly associated with invasive
nontyphoidal Salmonella disease in sub-Saharan Africa. The complete and closed
whole-genome sequence of strain D23580 revealed a genotype distinct from those of
broad-host-range strains commonly used in the laboratory (62). It exhibits considerably
more variation in gene content and coding capacity than laboratory strains like SL1344,
LT2, and ATCC 14028. D23580-speciﬁc genes are mainly due to the presence of two
novel prophages, BTP1 and BTP5, and two apparently cryptic plasmids, pBT1 and pBT2
(62). Strain D23580 also carries at least 25 additional genes on its virulence plasmid
pSLT-BT, due to the presence of a composite Tn21-like transposon, including antimi-
crobial and mercury resistance genes. Outside these regions, the chromosome of
D23580 is around 15 kb shorter than those of laboratory strains like SL1344 due to four
deletions impacting the coding sequences of 20 genes. Some of the deletions affect
virulence genes, a functional class unaffected by genome degradation, in laboratory
strains like SL1344 and 14028; examples include the pipD gene borne on SPI-5, involved
in enteropathogenesis and intestinal persistence (84, 85), mig-13 and pagO, involved in
persistent colonization in mice (85), and the allP and allB genes, involved in allantoin
metabolism (86). Deletions on a similar scale in other S. Typhimurium strains have not
been reported to date; indeed, with the exception of mobile elements, such as insertion
sequence (IS) elements, ICEs, and prophages, deletions of more than a few bases
occurring in strains of S. Typhimurium appear to be rare. Strain D23580 also contained
a greater number of strain-speciﬁc pseudogenes than SL1344 and 14028. With refer-
ence to the pseudogene content of strain LT2, a total of 24 pseudogenes speciﬁc to
strain D23580 were reported (62, 87). Notably, 11 were also pseudogenes or absent
from the S. Typhi or S. Paratyphi A genomes, perhaps the result of convergent evolution
to a disseminated disease lifestyle. These degraded genes include regulators and a
number of genes of unknown function. Several pseudogenes in D23580 have assigned
functions, including ratB, involved in intestinal persistence, lpxO, involved in modiﬁca-
tion of the lipid A component of the membrane, sseI, encoding an effector protein
secreted by the SPI-2-encoded type III secretion system, and bcsG, involved in cellulose
biosynthesis (16, 62, 80, 87). Two, bcsG and sseI, have been linked to ST313-speciﬁc
phenotypes in the environment and the host. The bcsG loss-of-function mutation was
linked to loss of multicellular behavior and sseI to hyperdissemination from the intes-
tine to systemic sites in the murine model of infection (16, 87). Finally, a single
nucleotide polymorphism in the promoter region of the pgtE gene results in increased
expression of the virulence factor PgtE, increasing resistance to serum killing and
modulating virulence in chicken infections (18).
A complete, closed reference genome is also available for strain 94-213, a repre-
sentative of S. Typhimurium DT2, associated with severe disseminated disease in
pigeons (19). Remarkably, despite the host adaptation exhibited by this pathovariant,
which is supported by epidemiological data (15, 30) and experimental infections of
mice (19), calves (38), and chicks (19), the gene content outside phage and IS elements
is identical to that of strain SL1344 (19). However, considerable genome degradation
was present in the DT2 genome, due to 21 pseudogenes that were full length in strains
LT2, SL1344, DT104, and D23580. Inactivation of two of these genes, pcgL and gtgE, has
previously been implicated in hyperdissemination and host restriction, respectively (88,
89). PcgL is a periplasmic D-alanyl–D-alanine dipeptidase whose inactivation results in
hypervirulence in mice by an as-yet-undeﬁned mechanism and represents an example
of loss of antivirulence genes (90). GtgE is a cysteine protease effector protein that
targets a family of Rab-GTPases and is widely distributed in broad-host-range Salmo-
nella strains (unpublished observations). Its absence in S. Typhi has been proposed to
determine, at least in part, the host restriction of this serovar (89) and may therefore
also contribute to the epidemiology of DT2. Inactivation in strain SL1344 of genes
orthologous to pseudogenes in DT2 did not result in attenuation of virulence in mice,
suggesting that combinations of these mutations may be required for the phenotype
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(19). However, DT2 was found to have a modiﬁed transcriptional response during
culture at elevated temperature, mimicking a feature of the avian host (19). A number
of genes were expressed at decreased levels in DT2 compared to their expression in the
broad-host-range strain SL1344, including many genes involved in motility, ﬂagellum
biosynthesis, and chemotaxis. Culture of DT2 at an elevated temperature also resulted
in a decreased inﬂammatory response upon interaction with epithelial cells in vitro,
consistent with the disease pathology described for this pathovariant. S. Typhi also
downregulates ﬂagella in the host, resulting in a decreased inﬂammatory response. This
results from regulation by the TviA regulator, which was acquired by S. Typhi on
Salmonella pathogenicity island 7 (SPI-7) (91). However, DT2 does not encode addi-
tional regulators, and the genetic basis of the DT2-speciﬁc transcriptional response to
elevated temperature is unknown (19).
MOLECULAR EPIDEMIOLOGY, PHYLOGEOGRAPHY, AND MICROEVOLUTION OF
SALMONELLA TYPHIMURIUM DURING CLONAL EXPANSION
Next-generation-sequencing technologies have made it possible to determine the
whole-genome sequences of tens of thousands of bacterial pathogens, enabling
discrimination of isolates at the highest possible resolution and the observation of
short-term evolution (92). Variations in genomes arising from single-nucleotide poly-
morphisms (SNPs) and insertions and deletions are readily identiﬁable. Sequence
variation, along with spatiotemporal data of the strain, has been used to infer the
spread of epidemic clones nationally and globally, as well as for outbreak detection,
source attribution, computation of molecular clock rates, and reconstruction of
maximum-likelihood and time-dependent phylogenetic trees using Bayesian inference.
Assembled sequences have been used to determine the pangenome, which has shed
light on the gene ﬂux that contributes to macro- and microevolutionary mechanisms,
including host adaptation and antimicrobial resistance (93). Draft genomes can be
assembled with short read sequences from next-generation technology that, while
typically composed of 50 to 150 contiguous sequences (contigs), allow the core and
accessory genomes of bacterial populations to be determined (94, 95).
Estimates of long-term substitution rates in bacteria, calibrated with geological and
ecological events, suggest that Salmonella and E. coli shared a common ancestor 100
to 150 million years ago, corresponding to a clock rate of around 1010 to 109
substitutions per site per year (96). Based on this calculation, we would not expect to
observe changes in the genome sequence associated with clonal expansion spanning
less than about 100 years. The sequence of an S. Paratyphi C genome recovered from
an 800-year-old human skeleton revealed the somewhat faster clock rate of 9.4  108
substitutions per site per year (97). Comparable substitution rates for the S. Typhimu-
rium clade as a whole have not been determined, as there was a lack of correlation
between the accumulation of SNPs (branch lengths) and dates of isolation (68).
However, several studies have reported short-term (10 to 50 years) substitution rates of
S. Typhimurium during clonal expansion in epidemics or outbreaks. A substitution rate
of 1.2 106 per site per year was calculated during clonal expansion of a DT135 clone
on a poultry farm in Australia over about 14 years, corresponding to 5 SNPs per genome
per year (68). A lower rate of approximately 3  107 per site per year, or 1 or 2 SNPs
per genome per year, was reported for two ST313 epidemic clones in sub-Saharan
Africa over a 45-year period (43), a global collection of DT104 isolates (98), and a DT160
epidemic clone over a 14-year period in New Zealand (35). Molecular clock rates have
been used to estimate the dates of major branching in phylogenetic trees of epidemic
clades and, in combination with site-of-isolation data, the spatiotemporal spread of
clones. In the DT160 epidemic in New Zealand (36), ancestral date reconstruction using
whole-genome sequences of 109 isolates predicted a shared common ancestor around
August 1997 (35). Furthermore, strains isolated from human clinical infections, poultry,
wild birds, felines, bovines, equines, canines, and the environment were dispersed
throughout the phylogenetic tree. These analyses were used to infer a point source of
the epidemic following introduction to New Zealand around 1997, followed by rapid
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spread through many animal populations (35). Similar Bayesian approaches estimated
the emergence of the DT104 pandemic clade as an antibiotic-sensitive clone around
1948 and the acquisition of the MDR phenotype around 10 years later by a single
sublineage, which later underwent clonal expansion and considerable diversiﬁcation
during the pandemic of the 1990s (98).
The vast majority of disseminated S. Typhimurium infections in sub-Saharan Africa
between 1995 and 2010 resulted from strains from two lineages (I and II) of ST313, (42,
43). Each lineage contains a distinct epidemic strain that initiated clonal expansion
around 1965 and 1985, respectively. The common ancestor of lineages I and II existed
some time before the clonal expansion of either strain, around the year 1800 (52).
Clonal expansion was concomitant with the independent acquisition by each epidemic
strain’s ancestor of distinct composite transposons bearing genes conferring resistance
to front-line drugs used to treat disseminated Salmonella infections in sub-Saharan
Africa. Epidemiological evidence from Malawi supports the inference from sequence
analysis that the lineage I clone emerged ﬁrst and was replaced rapidly in a clonal
sweep by the lineage II strains (99). The phylogenetic relationship of ST313 isolates
from countries across the region contained a strong geographical signature, with
isolates from each country clustering together. The inferred spatiotemporal spread of
the ST313 epidemic was similar to that of the spread of HIV across sub-Saharan Africa,
emerging initially in central Africa around 1980 and then spreading east and subse-
quently south, before ﬁnally arriving in West Africa some years later (43). ST313 strains
in human infections are rare outside sub-Saharan Africa. In routine surveillance in the
United Kingdom, just 2.6% of S. Typhimurium isolates from human clinical cases of
Salmonellosis were ST313. However, most of these were not part of the lineage I or II
epidemic groups from sub-Saharan Africa, but rather, were on closely related but
distinct lineages, representing previously unknown genetic diversity within ST313.
Remarkably, of the few UK isolates that were part of the Africa-associated lineage II, the
majority were associated with travel to sub-Saharan Africa, and many were associated
with extraintestinal infections. ST313 strains from the UK that were associated with
disseminated disease but not present in the lineage II clade were extremely rare (52).
The paucity of epidemiological surveillance across sub-Saharan Africa precludes tradi-
tional approaches to investigate epidemics, but the example of ST313, for which
whole-genome sequences from a relatively small number of isolates were employed to
reconstruct the phylogenetic history of isolates, demonstrates the utility of these
approaches in resource-poor settings.
Nucleotide substitutions that accumulate in genes are either synonymous (conserv-
ing the primary amino acid sequence) or nonsynonymous. The comparative rate of
synonymous to nonsynonymous SNPs (dN/dS) has been reported to be approximately
0.5 in the branches of a tree deﬁning reference strains of S. Typhimurium (62), and this
was also true over short time scales within epidemic clades (43, 68). This has been
interpreted as evidence that around half of all nonsynonymous substitutions are
deleterious and rapidly removed from the population (68). Most of the remaining
nonsynonymous SNPs are assumed to have little impact on the function of the encoded
protein or, alternatively, to result in changes in the function of the protein that are
either not under selective pressure or, indeed, are beneﬁcial. One scenario in which
mutations may be beneﬁcial is in the evolution of host-adapted pathovariants. In this
case, genes required for circulation in multiple hosts are no longer required, since the
pathovariant is restricted to a single host species. These may include genes encoding
adhesins that recognize species-speciﬁc receptors and those involved in nutrient
scavenging and associated metabolic genes no longer required in the restricted host
(79). A proﬁle hidden Markov model (HMM)-based method to identify functional
divergence in orthologous proteins called delta-bit score (DBS) (100) has been used to
prioritize polymorphic proteins in the S. Typhimurium DT2 pathovariant for further
investigation of their role in phenotypes of interest (19). Polymorphic proteins that
return a lower bit score than the orthologue from a broad-host-range comparator strain
contain changes in conserved domains that are therefore more likely to have altered
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function. The frequency distribution of DBS values for DT2 compared to those of
SL1344 orthologues revealed a skew from a normal distribution toward a positive score
(19), similar to that observed in a comparison of the host-adapted serovar S. Gallinarum
to the closely related broad-host-range serovar S. Enteritidis (100). This methodology
led to the identiﬁcation of a polymorphism in the tar gene of DT2 that altered the
chemotactic response in the DT2 pathovar. Flagellum-mediated motility and che-
motaxis are known to be important during the intestinal phase of infection (101, 102),
and the tar polymorphism is consistent with evolution of DT2 from an intestinal to an
extraintestinal pathovar.
Considering the generally limited differences in gene content when comparing the
genomes of pathovariants of S. Typhimurium on distinct lineages, a considerable amount
of microevolution occurs over short periods of time during clonal expansion of epidemic
clones. This variation has the potential to alter susceptibility to antimicrobials, antigenicity,
metabolism, and the outcome of infection. Although the MDR phenotype of epidemic
clones of S. Typhimurium appears to be important for their success, considerable sequence
variation is observed in antimicrobial resistance (AMR) gene loci during clonal expansion.
Variation in SGI-1 of the S. Typhimurium DT104 strains is known to occur through recom-
bination events (82), but analysis of the genome sequences of 359 strains isolated over a
22-year period revealed frequent and recurrent loss or gain of genes throughout the clade,
ranging from the entire SGI-1 to single AMR genes (64). Similar observations were made for
the AMR genes in the S. 4,[5],12:i: DT193/DT120 epidemic (59). Additional genotypic
variation outside the AMR locus was observed in the genome sequence of the S. 4,[5],12:i:
DT193/DT120 epidemic clone due to gene ﬂux from complex deletions around the ﬂjB
locus and the acquisition of prophages, an integrative conjugative element, and plasmids
(59). The genome ﬂanking the ﬂjB is hypervariable within S. 4,[5],12:i: DT193/DT120
epidemic strains. Reconstruction of the ancestral state with respect to this locus indicated
that early in the S. 4,[5],12:i: epidemic, the ﬂjB locus was intact and the strains were
biphasic. The presence of a composite transposon adjacent to the ﬂjB locus that contained
IS6 sequences known to mediate local deletions appears to have resulted in multiple
deletion events during clonal expansion. The deletions resulted in the emergence of the
monophasic phenotype within the clade on multiple occasions, due to deletion not only of
the ﬂjB locus but also up to 36 kb affecting 33 additional genes (59). The S. 4,[5],12:i: clade
also acquired on multiple independent occasions a novel phage designated mTmV that
carried the sopE gene. SopE is an effector protein with guanine exchange factor activity for
host Rho GTPases, which are involved in invasion of epithelial cells and induction of host
proinﬂammatory response (103). It has been associated with epidemic clones in the past
(104). It impacts pathogenicity (103) and imparts a competitive advantage to Salmonella
bacteria competing with host gut microbiota (74), and therefore, its acquisition is likely to
have had a considerable impact on the epidemic. Indeed, its acquisition resulted in clonal
expansion of strains bearing sopE within the epidemic, resulting in an increase in their
prevalence from low levels in 2005 to a third of isolates carrying the sopE gene by 2010 in
the UK epidemic (59). The transfer of phage in the intestine, boosted by the inﬂammatory
response of the host, has been reported for the sopE phage from SL1344 in experimental
infections of mice, demonstrating the potential for microevolution that changes the nature
of epidemics (105).
CONCLUSIONS
The combination of complete, closed, whole-genome sequences of key reference
strains of S. Typhimurium and thousands of draft whole-genome sequences represent-
ing a considerable amount of diversity within the group is dramatically changing our
understanding of this prototypical Salmonella serovar. A vast body of literature de-
scribes the biochemistry, physiology, and host-pathogen interactions of a vanishingly
small number of strains of S. Typhimurium. For the purposes of quantitative risk
assessment for foodborne disease, Salmonella has been considered homogenous, but
a greater understanding of the diversity of genotypes and their interactions with the
host and environment now has the potential to reﬁne how we view the risk and provide
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the tools needed to design appropriate interventions. The genomic variation of S.
Typhimurium pathovariants provides a window into the events that lead to the
formation of new pathogens. The gene ﬂux, genome degradation, and alteration of
transcriptional responses associated with adaptation to new hosts and environmental
niches are relatively recent adaptations in S. Typhimurium pathovariants. Perhaps the
most exciting insights from high-throughput sequencing are applications in surveil-
lance and molecular epidemiology that provide insights into source attribution and the
dynamics of epidemic spread, impossible from traditional surveillance approaches. The
globalized food chain requires global solutions to control foodborne pathogens, and
the combination of technological and bioinformatic developments will make it possible
to integrate pathogen surveillance around the world.
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